VEEV

Technology Services
$158.86 +1.67%
Back to Screener
Live Volume
2,095,444
Market Cap
25.93 B
P/E Ratio
29.33
52W Peak Proximity
%51

ANALYSIS CENTER

AI Rating & Analysis: VEEV stock analysis with hallucination-free AI screener tools — real-time price, volume, P/E ratio, 52-week proximity and sector performance data for Technology Services. AI-powered stock analysis and research platform.
GOD-TIER PROMPT ACTIVE
Investment report at Goldman Sachs + Bridgewater + Renaissance Technologies level
10 sections: Tables • Charts • Bullet Points. Plain text PROHIBITED.
1Executive Summary
2Fair Value
3Fundamental Analysis
4Technical Analysis
5Scenario Analysis
6Competitor Comparison
7Dividend Return
8Risk Analysis
9Catalyst Calendar
10Action Plan
HOW IT WORKS: When you click an AI button below, this prompt is instantly copied to your clipboard. Simply Paste (CTRL+V) it into the chat box of the opened AI assistant to run the analysis.
İpucu: Tip: Use our TradingView charts for technical analysis. Evaluate alongside the AI report.
Open Advanced Chart
TradingView Charts
• 15-min delayed price feed • 100+ technical indicators • Sub-second updates • Professional drawing tools
Affiliate links — DocuRefinery may earn a commission when you open an account.

Interactive Brokers

SEC, FINRA, FCA, ASIC Regulation $0 Min. Deposit
Access 150+ global markets. Stocks, ETFs, Options, Futures, Forex.
Open Account

TD Ameritrade (Schwab)

SEC, FINRA Regulation $0 Min. Deposit
Industry-leading trading platforms and comprehensive education.
Open Account
All investing involves risk, including the possible loss of principal. Past performance does not guarantee future results.

Latest News — VEEV

Veeva Systems Inc. — Company Profile & Analysis

Veeva Systems Inc., originally incorporated as Verticals onDemand, Inc. in 2007, rebranded to Veeva Systems Inc. in April 2009. Headquartered in Pleasanton, California, Veeva was founded with a clear mission: to provide cloud-based software solutions specifically tailored for the life sciences industry. Recognizing the unique and complex regulatory, operational, and commercial challenges faced by pharmaceutical, biotechnology, and medical device companies, Veeva aimed to deliver innovative, industry-specific applications that would enhance efficiency, compliance, and collaboration across the entire product lifecycle, from R&D to commercialization. This focused approach allowed Veeva to build deep domain expertise and develop solutions that truly address the intricate needs of its specialized clientele. The company's foundational philosophy is to accelerate the digital transformation of life sciences organizations, enabling them to bring innovative treatments to patients faster and more safely.

Veeva's comprehensive suite of offerings is broadly categorized into Veeva Commercial Cloud, Veeva Data Cloud, and Veeva Development Cloud, complemented by professional and support services. The Veeva Commercial Cloud is critical for sales and marketing, featuring Veeva Vault CRM Suite for customer relationship management, Veeva Medical for managing medical content, Veeva PromoMats for end-to-end content and digital asset management, and Veeva Crossix for advanced analytics platforms tailored for pharmaceutical brands. The Veeva Data Cloud provides essential data solutions like Veeva OpenData for customer reference data, Veeva Link for deep scientific and medical insights, Veeva Compass for de-identified patient data, and Veeva CRM Pulse for engagement metrics. The Veeva Development Cloud supports R&D and quality, encompassing Veeva Clinical Platform for trial execution, Veeva Clinical Data Management, Veeva Safety for pharmacovigilance, Veeva RIM for regulatory information management, and Veeva Quality Cloud for quality management. These platforms are underpinned by a commitment to continuous innovation, leveraging cloud technology to deliver scalable, secure, and integrated solutions that streamline complex workflows and accelerate time-to-market for life-saving therapies.

Veeva Systems holds a dominant market position as the leading provider of cloud-based software for the global life sciences industry. Its specialized focus has allowed it to capture a significant share of the market, serving a vast array of pharmaceutical, biotechnology, and medical device companies, from emerging biotechs to the largest global enterprises. With operations spanning North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America, Veeva boasts an impressive global footprint, supporting its clients wherever they operate. The company's target demographic includes sales representatives, marketing teams, medical affairs professionals, clinical operations staff, regulatory affairs specialists, and quality assurance personnel within these life sciences organizations. Veeva's solutions are designed to meet the stringent regulatory requirements and complex operational demands inherent in these highly regulated industries, making it an indispensable partner for companies navigating drug development, commercialization, and post-market surveillance.

Looking ahead, Veeva Systems is strategically positioned for continued growth, driven by the increasing digitalization of the life sciences industry and the ongoing need for specialized, compliant, and efficient software solutions. The company's future outlook involves deepening its penetration within existing client bases, expanding into new therapeutic areas and emerging markets, and continuously enhancing its product portfolio through organic innovation and strategic acquisitions. Key strategic directions include further integrating its Commercial, Data, and Development Clouds to offer a more unified platform, leveraging artificial intelligence and machine learning to provide more predictive insights, and expanding its consulting services to help clients optimize their business processes. Veeva's commitment to customer success, coupled with its robust R&D pipeline and strong financial health, underpins its long-term vision to be the essential technology partner for the life sciences industry, enabling companies to bring new treatments to patients faster and more efficiently.

Economic Moat Veeva's sustainable competitive advantage stems from its deep specialization and comprehensive, integrated cloud platform tailored exclusively for the highly regulated life sciences industry. The significant switching costs associated with migrating complex, mission-critical systems, combined with the network effects of its widely adopted industry-standard solutions, create a formidable barrier to entry for competitors. Furthermore, Veeva's continuous innovation and strong customer relationships solidify its position as an indispensable technology partner, making it extremely difficult for clients to switch to alternative providers.
CEO Mr. Peter P. Gassner
Employees 7,928
Headquarters United States
Market Competitors
Smart Tags
#LifeSciencesTech #CloudSoftware #Biotech #Pharmaceuticals #CRM #ClinicalTrials #RegulatoryCompliance #SaaS

Market Insights & Investor Q&A — VEEV

Frequently Asked Questions

How can I use a free, no registration AI prompt to analyze the VEEV stock?
On the DocuRefinery platform you’ll find a ready-made prompt that pulls instant verified data for VEEV. Just select the ticker, enable the "no registration" option and the system fetches the latest price, volume and key metrics in seconds, delivering a complete analysis without any manual data gathering.
What does an AI‑driven risk analysis look like for VEEV using ready solutions?
The ready‑solution template scans VEEV’s historical volatility, beta and liquidity automatically. By including the phrase "risk analysis" in the prompt, the platform pulls those parameters instantly and generates a risk score, giving you a clear picture of exposure without building a custom model.
How does AI‑based trend detection for VEEV differ from traditional technical analysis?
Traditional technical analysis relies on manually reviewing charts and indicators. An AI‑based trend detection prompt examines millions of data points across the past five years, uncovering hidden correlations and projecting possible trend directions. The result is delivered as an instant, ready‑solution report that highlights likely price movements.

Deep Analysis

AI‑Powered Ready Solutions for VEEV Investment Analysis

When evaluating stocks like VEEV, AI methodologies bring speed and precision to risk analysis, trend detection, and balance‑sheet scanning. Traditional analysis can take hours of data collection and model building, whereas a ready AI prompt reduces the workflow to seconds.

DocuRefinery offers instant access to verified data with a free, no‑signup experience. A single command pulls VEEV’s price action, volume trends and core financial indicators, packaging them into a customizable report. Investors no longer need to construct complex models to get a deep dive into the stock.

The AI‑driven ready‑solution approach reduces bias and expands data coverage compared to conventional methods. By tweaking the prompt, users can tailor the analysis to their risk appetite—for example, adding a volatility filter to surface only low‑risk signals. This flexibility enables faster, more reliable investment decisions.